Simply Wall St.
ICON (ICLR) Is Down 7.8% After Revenue Overstatement Disclosure And Accounting Review - Has The Bull Case Changed?
📉
AI Sentiment
Negative
2/10
- Home
- ICLR
ICLR
ICON plc
as of 03-24-2026 2:58pm EST
$103.26
+$2.91
+2.90%
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
| Founded: | 1990 | Country: | Ireland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 7.1B | IPO Year: | 2001 |
| Target Price: | $182.08 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $66.57 - $211.00 | Next Earning Date: | 04-29-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | -0.78% | Revenue Growth (next year): | -0.68% |
| P/E Ratio: | 12.91 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | -21.55% |
Latest ICON plc News
ICLR Breaking Stock News: Dive into ICLR Ticker-Specific Updates for Smart Investing
Compare ICLR vs Leading Stocks
See how ICLR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ICLR ICON plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.